2024-09-01 2025-08-31 2025-08-31 false 10307723 GREENZEN LTD 2026-05-13 10831 false iso4217:GBP xbrli:pure 10307723 2024-08-31 10307723 2025-08-31 10307723 2024-09-01 2025-08-31 10307723 2023-08-31 10307723 2024-08-31 10307723 2023-09-01 2024-08-31 10307723 bus:SmallEntities 2024-09-01 2025-08-31 10307723 bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 10307723 bus:FullAccounts 2024-09-01 2025-08-31 10307723 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 10307723 core:WithinOneYear 2025-08-31 10307723 core:AfterOneYear 2025-08-31 10307723 core:WithinOneYear 2024-08-31 10307723 core:AfterOneYear 2024-08-31 10307723 core:ShareCapital 2025-08-31 10307723 core:SharePremium 2025-08-31 10307723 core:RevaluationReserve 2025-08-31 10307723 core:OtherReservesSubtotal 2025-08-31 10307723 core:RetainedEarningsAccumulatedLosses 2025-08-31 10307723 core:ShareCapital 2024-08-31 10307723 core:SharePremium 2024-08-31 10307723 core:RevaluationReserve 2024-08-31 10307723 core:OtherReservesSubtotal 2024-08-31 10307723 core:RetainedEarningsAccumulatedLosses 2024-08-31 10307723 core:LandBuildings 2025-08-31 10307723 core:PlantMachinery 2025-08-31 10307723 core:Vehicles 2025-08-31 10307723 core:FurnitureFittings 2025-08-31 10307723 core:OfficeEquipment 2025-08-31 10307723 core:NetGoodwill 2025-08-31 10307723 core:IntangibleAssetsOtherThanGoodwill 2025-08-31 10307723 core:ListedExchangeTraded 2025-08-31 10307723 core:UnlistedNon-exchangeTraded 2025-08-31 10307723 core:LandBuildings 2024-08-31 10307723 core:PlantMachinery 2024-08-31 10307723 core:Vehicles 2024-08-31 10307723 core:FurnitureFittings 2024-08-31 10307723 core:OfficeEquipment 2024-08-31 10307723 core:NetGoodwill 2024-08-31 10307723 core:IntangibleAssetsOtherThanGoodwill 2024-08-31 10307723 core:ListedExchangeTraded 2024-08-31 10307723 core:UnlistedNon-exchangeTraded 2024-08-31 10307723 core:LandBuildings 2024-09-01 2025-08-31 10307723 core:PlantMachinery 2024-09-01 2025-08-31 10307723 core:Vehicles 2024-09-01 2025-08-31 10307723 core:FurnitureFittings 2024-09-01 2025-08-31 10307723 core:OfficeEquipment 2024-09-01 2025-08-31 10307723 core:NetGoodwill 2024-09-01 2025-08-31 10307723 core:IntangibleAssetsOtherThanGoodwill 2024-09-01 2025-08-31 10307723 core:ListedExchangeTraded 2024-09-01 2025-08-31 10307723 core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 10307723 core:MoreThanFiveYears 2024-09-01 2025-08-31 10307723 core:Non-currentFinancialInstruments 2025-08-31 10307723 core:Non-currentFinancialInstruments 2024-08-31 10307723 dpl:CostSales 2024-09-01 2025-08-31 10307723 dpl:DistributionCosts 2024-09-01 2025-08-31 10307723 core:LandBuildings 2024-09-01 2025-08-31 10307723 core:PlantMachinery 2024-09-01 2025-08-31 10307723 core:Vehicles 2024-09-01 2025-08-31 10307723 core:FurnitureFittings 2024-09-01 2025-08-31 10307723 core:OfficeEquipment 2024-09-01 2025-08-31 10307723 dpl:AdministrativeExpenses 2024-09-01 2025-08-31 10307723 core:NetGoodwill 2024-09-01 2025-08-31 10307723 core:IntangibleAssetsOtherThanGoodwill 2024-09-01 2025-08-31 10307723 dpl:GroupUndertakings 2024-09-01 2025-08-31 10307723 dpl:ParticipatingInterests 2024-09-01 2025-08-31 10307723 dpl:GroupUndertakings core:ListedExchangeTraded 2024-09-01 2025-08-31 10307723 core:ListedExchangeTraded 2024-09-01 2025-08-31 10307723 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 10307723 core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 10307723 dpl:CostSales 2023-09-01 2024-08-31 10307723 dpl:DistributionCosts 2023-09-01 2024-08-31 10307723 core:LandBuildings 2023-09-01 2024-08-31 10307723 core:PlantMachinery 2023-09-01 2024-08-31 10307723 core:Vehicles 2023-09-01 2024-08-31 10307723 core:FurnitureFittings 2023-09-01 2024-08-31 10307723 core:OfficeEquipment 2023-09-01 2024-08-31 10307723 dpl:AdministrativeExpenses 2023-09-01 2024-08-31 10307723 core:NetGoodwill 2023-09-01 2024-08-31 10307723 core:IntangibleAssetsOtherThanGoodwill 2023-09-01 2024-08-31 10307723 dpl:GroupUndertakings 2023-09-01 2024-08-31 10307723 dpl:ParticipatingInterests 2023-09-01 2024-08-31 10307723 dpl:GroupUndertakings core:ListedExchangeTraded 2023-09-01 2024-08-31 10307723 core:ListedExchangeTraded 2023-09-01 2024-08-31 10307723 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-09-01 2024-08-31 10307723 core:UnlistedNon-exchangeTraded 2023-09-01 2024-08-31 10307723 core:NetGoodwill 2025-08-31 10307723 core:IntangibleAssetsOtherThanGoodwill 2025-08-31 10307723 core:LandBuildings 2025-08-31 10307723 core:PlantMachinery 2025-08-31 10307723 core:Vehicles 2025-08-31 10307723 core:FurnitureFittings 2025-08-31 10307723 core:OfficeEquipment 2025-08-31 10307723 core:AfterOneYear 2025-08-31 10307723 core:WithinOneYear 2025-08-31 10307723 core:ListedExchangeTraded 2025-08-31 10307723 core:UnlistedNon-exchangeTraded 2025-08-31 10307723 core:ShareCapital 2025-08-31 10307723 core:SharePremium 2025-08-31 10307723 core:RevaluationReserve 2025-08-31 10307723 core:OtherReservesSubtotal 2025-08-31 10307723 core:RetainedEarningsAccumulatedLosses 2025-08-31 10307723 core:NetGoodwill 2024-08-31 10307723 core:IntangibleAssetsOtherThanGoodwill 2024-08-31 10307723 core:LandBuildings 2024-08-31 10307723 core:PlantMachinery 2024-08-31 10307723 core:Vehicles 2024-08-31 10307723 core:FurnitureFittings 2024-08-31 10307723 core:OfficeEquipment 2024-08-31 10307723 core:AfterOneYear 2024-08-31 10307723 core:WithinOneYear 2024-08-31 10307723 core:ListedExchangeTraded 2024-08-31 10307723 core:UnlistedNon-exchangeTraded 2024-08-31 10307723 core:ShareCapital 2024-08-31 10307723 core:SharePremium 2024-08-31 10307723 core:RevaluationReserve 2024-08-31 10307723 core:OtherReservesSubtotal 2024-08-31 10307723 core:RetainedEarningsAccumulatedLosses 2024-08-31 10307723 core:NetGoodwill 2023-08-31 10307723 core:IntangibleAssetsOtherThanGoodwill 2023-08-31 10307723 core:LandBuildings 2023-08-31 10307723 core:PlantMachinery 2023-08-31 10307723 core:Vehicles 2023-08-31 10307723 core:FurnitureFittings 2023-08-31 10307723 core:OfficeEquipment 2023-08-31 10307723 core:AfterOneYear 2023-08-31 10307723 core:WithinOneYear 2023-08-31 10307723 core:ListedExchangeTraded 2023-08-31 10307723 core:UnlistedNon-exchangeTraded 2023-08-31 10307723 core:ShareCapital 2023-08-31 10307723 core:SharePremium 2023-08-31 10307723 core:RevaluationReserve 2023-08-31 10307723 core:OtherReservesSubtotal 2023-08-31 10307723 core:RetainedEarningsAccumulatedLosses 2023-08-31 10307723 core:AfterOneYear 2024-09-01 2025-08-31 10307723 core:WithinOneYear 2024-09-01 2025-08-31 10307723 core:Non-currentFinancialInstruments core:CostValuation 2024-09-01 2025-08-31 10307723 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-09-01 2025-08-31 10307723 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-09-01 2025-08-31 10307723 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-09-01 2025-08-31 10307723 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 10307723 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 10307723 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 10307723 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 10307723 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 10307723 core:Non-currentFinancialInstruments core:CostValuation 2025-08-31 10307723 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-08-31 10307723 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-08-31 10307723 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-08-31 10307723 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-08-31 10307723 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-08-31 10307723 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-08-31 10307723 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-08-31 10307723 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-08-31 10307723 core:Non-currentFinancialInstruments core:CostValuation 2024-08-31 10307723 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-08-31 10307723 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-08-31 10307723 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-08-31 10307723 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-08-31 10307723 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-08-31 10307723 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-08-31 10307723 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-08-31 10307723 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-08-31 10307723 bus:Director1 2024-09-01 2025-08-31 10307723 core:FurnitureFittingsToolsEquipment 2024-08-31 10307723 core:FurnitureFittingsToolsEquipment 2024-09-01 2025-08-31 10307723 core:FurnitureFittingsToolsEquipment 2025-08-31

GREENZEN LTD

Registered Number
10307723
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2025

GREENZEN LTD
Company Information
for the year from 1 September 2024 to 31 August 2025

Director | BARADARAN, Sean

Registered Address | 9 Woodland Crescent
| Needleman Street
| London
| SE16 6YN

Registered Number | 10307723 (England and Wales)

GREENZEN LTD
Balance Sheet as at
31 August 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 6,211 |  |  |  | 4,621
|  |  |  | 6,211 |  |  |  | 4,621
Current assets |  |  |  |  |  |  |  |
Debtors |  | 15,479 |  |  |  | 10,733 |  |
Cash at bank and on hand |  | 44,221 |  |  |  | 52,738 |  |
|  | 59,700 |  |  |  | 63,471 |  |
Creditors amounts falling due within one year | 4 | (25,328) |  |  |  | (29,294) |  |
Net current assets (liabilities) |  |  |  | 34,372 |  |  |  | 34,177
Total assets less current liabilities |  |  |  | 40,583 |  |  |  | 38,798
Net assets |  |  |  | 40,583 |  |  |  | 38,798
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 1 |  |  |  | 1
Profit and loss account |  |  |  | 40,582 |  |  |  | 38,797
Shareholders' funds |  |  |  | 40,583 |  |  |  | 38,798

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 13 May 2026, and are signed on its behalf by:
BARADARAN, Sean Director Registered Company No. 10307723

GREENZEN LTD
Notes to the Financial Statements
for the year ended 31 August 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Revenue from sale of goods
--- | ---
| Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Tangible fixed assets and depreciation
--- | ---
| All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

|  | Reducing balance (%)
| Plant and machinery | 20
| Fixtures and fittings | 20
| Office Equipment | 20

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 4 |  | 3

3. | Tangible fixed assets
--- | ---

|  | Plant & machinery |  | Fixtures & fittings |  | Office Equipment |  | Total
--- | --- | --- | --- | --- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
| Cost or valuation
| At 01 September 24 | 8,325 |  | 2,203 |  | 2,267 |  | 12,795
| Additions | 2,090 |  | 1,052 |  | - |  | 3,142
| At 31 August 25 | 10,415 |  | 3,255 |  | 2,267 |  | 15,937
| Depreciation and impairment
| At 01 September 24 | 6,059 |  | 1,106 |  | 1,009 |  | 8,174
| Charge for year | 871 |  | 430 |  | 251 |  | 1,552
| At 31 August 25 | 6,930 |  | 1,536 |  | 1,260 |  | 9,726
| Net book value
| At 31 August 25 | 3,485 |  | 1,719 |  | 1,007 |  | 6,211
| At 31 August 24 | 2,266 |  | 1,097 |  | 1,258 |  | 4,621

4. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | 8,354 |  | 5,458
| Bank borrowings and overdrafts | 9,900 |  | 7,337
| Amounts owed to related parties | 6,768 |  | 12,739
| Taxation and social security | 213 |  | 3,760
| Accrued liabilities and deferred income | 93 |  | -
| Total | 25,328 |  | 29,294

| A total loan balance of £6,876 has been recognised in the financial statements. Of this: £4,000 has been classified as a current liability, being the portion due for repayment within 12 months

5. | Creditors: amounts due after one year
--- | ---
| A total loan balance of £6,876 has been recognised in the financial statements. Of this £2,876 has been classified as a non-current liability, representing the portion of the loan due for repayment after more than 12 months from the reporting date

6. | Related party transactions
--- | ---
| At the year end, the company owed £3,017.74 to the director of the company. This balance represented funds introduced by the director to support the company’s working capital requirements. The company also owed £3,750 to Greenzen Health Ltd, a related party, at the reporting date. The balance was unsecured, interest-free and repayable on demand.